PATENT CLAIM ANALYSIS

Application Number: 16039877
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-11
Patent Classification: ["514", "219000"]

Abstract:
Provided herein are substituted fused quadracyclic compounds useful as inhibitors of MK2. The invention further provides pharmaceutical compositions of the compounds of the invention. The invention also provides medical uses of substituted fused quadracyclic compounds.

Claim (Index 70):
The method of  claim 39 , wherein R 2  is \u2014C(O)\u2014OR 41 ; and\n R 41  is optionally substituted alkyl, alkenyl, cycloalkyl, (cycloalkyl)alkyl, aryl, or aralkyl.

Metadata:
- Claim Count in Document: 110.0
- Percentile: 95.0
- Lexical Diversity: 1.65217
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15397212', '13249166', '14448160', '12598882', '14728562']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7567578598444437
- 35 USC 102 Novelty (BERT): 0.5823806217007346
- Combined Prediction Score: 0.7393201360300727
- Mean Citation Score: 328.424554
- Max Citation Score: 461.9091
- Similarity Product: 424.1927541588128

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test